Clinical Utility of Polygenic Risk Scores for Embryo Selection: A Points to Consider Statement of the American College of Medical Genetics and Genomics (ACMG) Editorial Comment

被引:0
|
作者
Grebe, Theresa A. [1 ,2 ]
Khushf, George [3 ]
Greally, John M. [4 ]
Turley, Patrick [5 ,6 ]
Foyouzi, Nastaran [7 ]
Rabin-Havt, Sara [8 ]
Berkman, Benjamin E. [9 ,10 ]
Pope, Kathleen [11 ,12 ]
Vatta, Matteo [13 ]
Kaur, Shagun [1 ,2 ]
机构
[1] Phoenix Childrens, Phoenix, AZ 85034 USA
[2] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85721 USA
[3] Univ South Carolina, Dept Philosophy, Columbia, SC USA
[4] Albert Einstein Coll Med, Dept Genet & Pediat, Bronx, NY USA
[5] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA USA
[6] Univ Southern Calif, Dept Econ, Los Angeles, CA USA
[7] San Diego Fertil Ctr IvyFertil, San Diego, CA USA
[8] Albert Einstein Coll Med, Montefiore Med Ctr, Dept OB GYN, Bronx, NY USA
[9] NIH, Dept Bioeth, Bethesda, MD USA
[10] Natl Human Genome Res Inst, Bethesda, MD USA
[11] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA
[12] Univ S Florida, Coll Publ Hlth, Tampa, FL USA
[13] Invitae Corp, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:566 / 568
页数:3
相关论文
共 50 条
  • [41] ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendola, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Gordon, Adam S.
    Harrison, Steven M.
    Hershberger, Ray E.
    Klein, Teri E.
    Richards, C. Sue
    Stewart, Douglas R.
    Martin, C. L.
    GENETICS IN MEDICINE, 2023, 25 (08)
  • [42] ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendla, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Gordon, Adam S.
    Harrison, Steven M.
    Hershberger, Ray E.
    Klein, Teri E.
    Richards, Carolyn Sue
    Stewart, Douglas R.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2022, 24 (07) : 1407 - 1414
  • [43] ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Chung, Wendy K.
    Gordon, Adam S.
    Herman, Gail E.
    Klein, Teri E.
    Stewart, Douglas R.
    Amendola, Laura M.
    Adelman, Kathy
    Bale, Sherri J.
    Gollob, Michael H.
    Harrison, Steven M.
    Hershberger, Ray E.
    McKelvey, Kent
    Richards, C. Sue
    Vlangos, Christopher N.
    Watson, Michael S.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2021, 23 (08) : 1381 - 1390
  • [44] Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG)
    South, Sarah T.
    McClure, Michelle
    Astbury, Caroline
    Bashford, Michael T.
    Benkendorf, Judith
    Esplin, Edward D.
    Monaghan, Kristin G.
    Oglesbee, Devin
    Sutton, V. Reid
    Watson, Michael S.
    GENETICS IN MEDICINE, 2020, 22 (06) : 983 - 985
  • [45] Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Gordon, Adam S.
    Amendola, Laura M.
    Adelman, Kathy
    Bale, Sherri J.
    Chung, Wendy K.
    Gollob, Michael H.
    Harrison, Steven M.
    Herman, Gail E.
    Hershberger, Ray E.
    Klein, Teri E.
    McKelvey, Kent
    Richards, C. Sue
    Vlangos, Christopher N.
    Stewart, Douglas R.
    Watson, Michael S.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2021, 23 (08) : 1391 - 1398
  • [46] Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
    Pal, Tuya
    Agnese, Doreen
    Daly, Mary
    La Spada, Albert
    Litton, Jennifer
    Wick, Myra
    Klugman, Susan
    Esplin, Edward D.
    Jarvik, Gail P.
    GENETICS IN MEDICINE, 2020, 22 (04) : 681 - 685
  • [47] Consideration of disease penetrance in the selection of secondary fi ndings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Gordon, Adam S.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendola, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Harrison, Steven M.
    Hershberger, Ray E.
    Richards, C. Sue
    Stewart, Douglas R.
    Martin, Christa Lese
    Miller, David T.
    GENETICS IN MEDICINE, 2024, 26 (07)
  • [48] Clinical evaluation and etiologic diagnosis of hearing loss: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
    Li, Marilyn M.
    Abou Tayoun, Ahmad
    DiStefano, Marina
    Pandya, Arti
    Rehm, Heidi L.
    Robin, Nathaniel H.
    Schaefer, Amanda M.
    Yoshinaga-Itano, Christine
    GENETICS IN MEDICINE, 2022, 24 (07) : 1392 - 1406
  • [49] Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
    Stewart, Douglas R.
    Korf, Bruce R.
    Nathanson, Katherine L.
    Stevenson, David A.
    Yohay, Kaleb
    GENETICS IN MEDICINE, 2018, 20 (07) : 671 - 682